Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Enanta Pharmaceutica
(NQ:
ENTA
)
9.570
+0.040 (+0.42%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
177,566
Open
9.520
Bid (Size)
9.080 (1)
Ask (Size)
10.13 (1)
Prev. Close
9.530
Today's Range
9.360 - 9.650
52wk Range
8.510 - 17.80
Shares Outstanding
21,055,392
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
A Glimpse Into The Expert Outlook On Enanta Pharma Through 4 Analysts
October 09, 2024
Via
Benzinga
Enanta Pharmaceuticals Reports Antiviral For Respiratory Syncytial Virus Reduces Virus Levels, Symptoms In Study
September 26, 2024
Enanta Pharmaceuticals' EDP-323 shows promising Phase 2a trial results, significantly reducing RSV viral load and symptoms while maintaining a favorable safety profile. EDP-323 offers potential as a...
Via
Benzinga
Performance
YTD
-5.06%
-5.06%
1 Month
-24.23%
-24.23%
3 Month
-24.23%
-24.23%
6 Month
-23.26%
-23.26%
1 Year
+7.05%
+7.05%
More News
Read More
Enanta Pharmaceuticals Announces Positive Topline Results for EDP-323 in a Phase 2a Human Challenge Study of Healthy Adults Infected With Respiratory Syncytial Virus (RSV)
September 26, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals to Participate in Investor Conferences in September
September 03, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Recap: Enanta Pharma Q1 Earnings
February 07, 2024
Via
Benzinga
Earnings Scheduled For February 7, 2024
February 07, 2024
Via
Benzinga
ENTA Stock Earnings: Enanta Pharma Beats EPS, Beats Revenue for Q3 2024
August 05, 2024
Via
InvestorPlace
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter
August 05, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference
May 29, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference
May 07, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Earnings Preview For Enanta Pharma
February 06, 2024
Via
Benzinga
ENTA Stock Earnings: Enanta Pharma Misses EPS, Beats Revenue for Q2 2024
May 06, 2024
Via
InvestorPlace
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET
May 06, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 30, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer
April 30, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024
April 29, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
April 17, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
March 06, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET
February 07, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 06, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023
January 31, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2024 Outlook at the 42nd Annual J.P. Morgan Healthcare Conference
January 04, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Enanta Pharmaceuticals to Participate at Evercore ISI HealthCONx Conference
November 22, 2023
From
Enanta Pharmaceuticals, Inc.
Via
Business Wire
Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
November 21, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.